• Native and Derivative Cyclodextrins trappsol

    Used in R & D and specialty manufacturing

    Read more
  • Cyclodextrin Complexes aquaplex

    Improves ingredient solubility for food, nutritional and pharmaceutical formulations

    Read more
  • API Grade Cyclodextrins trappsol cyclo

    Cyclodextrins as active pharmaceutical ingredients

    Read more
image description

CTD Holdings, Inc (CTDH)

CTD Holdings, Inc. is a family of biotechnology growth companies based on cyclodextrin chemistry. Its individual divisions distribute and manufacture the trademarked Trappsol® and Aquaplex® cyclodextrins, cyclodextrin derivatives, and cyclodextrin complexes for biotechnology and life science companies involved in research, pharmaceutical, medical device, cosmetics and nutrition markets. Sphingo Biotechnology, Inc. is developing Trappsol® Cyclo™, an orphan drug designated product, for the treatment of Niemann Pick Type C, a rare and fatal genetic disease in young children. NanoSonic Products, Inc. operates the world's only cGMP pulse drying facility for the production of our UltraPure™ line of cyclodextrin derivatives and pharmaceutical grade Aquaplex® cyclodextrin complexes. CTD, Inc. supplies cyclodextrins to biotechnology and life science researchers around the globe from the world's largest catalog of cyclodextrins. The companies offer a wide variety of cyclodextrin related manufacturing services to worldwide customers, including custom formulation, manufacturing, and commercial scale supply of pharmaceutical grade cyclodextrin complexes.

Recent News:

  • Jul 28 2015, 7:00 AM EDT Dr. Camilo Vieira and Pessoa Parents Join CTD Holdings Family and Physicians Listening Circle on NPC Treatment
  • Jul 13 2015, 7:00 AM EDT CTD Holdings Receives $1.3 Million Follow-On Investment Led by U.S. Pharmacia Investment Arm Novit L.P.
  • Jul 10 2015, 9:15 AM EDT Dr. Elin Haf Davies Withdraws From CTD Holdings' Family and Physicians Listening Circle on NPC Treatment